Publications by authors named "V O Solodushko"

is a Gram-negative, curved, rod-shaped organism that can cause sepsis due to either gastroenteritis when ingested (usually via raw oysters) or skin infections when introduced into cuts or abrasions. Found in estuarine waters (coastal waters where fresh water from streams mixes with salt water from the ocean resulting in water of intermediate salinity (i.e.

View Article and Find Full Text PDF

Synthesizing mRNA in vitro is a standard and simple procedure. Adding the 5' cap and 3' polyadenylated (poly(A)) tail to make this mRNA functional for use as a vaccine or therapy increases the time and cost of production and usually decreases the yield, however. We designed mRNA that lacked a cap and poly(A) tail but included an internal ribosomal entry site (IRES) to initiate protein translation.

View Article and Find Full Text PDF
Article Synopsis
  • Chikungunya virus (CHIKV) can cause long-lasting joint pain, especially in tropical and subtropical areas, and currently, there are no approved vaccines to prevent it.
  • Researchers are exploring DNA-launched virus-like particle (VLP) vaccines as a safer alternative to traditional vaccines, but there is a lack of comprehensive mouse models that include both sexes for testing.
  • A study evaluated these vaccines using engineered virus strains in male and female mice, revealing the potential effectiveness of DNA-launched VLP vaccines and highlighting gender differences in viral load, which could influence future vaccine development.
View Article and Find Full Text PDF

I is a cation current permeating the ISOC channel. In pulmonary endothelial cells, I activation leads to formation of inter-endothelial cell gaps and barrier disruption. The immunophilin FK506-binding protein 51 (FKBP51), in conjunction with the serine/threonine protein phosphatase 5C (PPP5C), inhibits I .

View Article and Find Full Text PDF

DNA vaccines have great potential to control infectious disease, particularly those caused by intracellular organisms. They are inexpensive to produce and can be quickly modified to combat emerging infectious threats, but often fail to generate a strong immunologic response limiting enthusiasm for their use in humans and animals. To improve the immunogenic response, we developed a DNA vaccine in which the F protein ectodomain of Respiratory Syncytial Virus (RSV-F) was covalently linked to specific antigens of interest.

View Article and Find Full Text PDF